Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
Clinical trial NCT03907800 · UNKNOWN
Trial details
- NCT number
- NCT03907800
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2022-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.